<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05798013</url>
  </required_header>
  <id_info>
    <org_study_id>ENHEARTEN</org_study_id>
    <nct_id>NCT05798013</nct_id>
  </id_info>
  <brief_title>Effectiveness of Digital Health Management on Patients With Head and Neck Vascular Stenosis</brief_title>
  <official_title>Effectiveness of Digital Health Management on Patients With Head and Neck Vascular Stenosis: A Multicenter, Cluster Randomized Controlled Trial Based on Chinese Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yi Yang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Hospital of Jilin University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of digital health management for&#xD;
      intervention on Chinese population with head and neck vascular stenosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2023</start_date>
  <completion_date type="Anticipated">April 2027</completion_date>
  <primary_completion_date type="Anticipated">April 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>New-onset stroke events at 24 months</measure>
    <time_frame>24 months</time_frame>
    <description>New-onset stroke events include ischemic stroke, transient ischemic attack, and hemorrhagic stroke.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>New-onset stroke events at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>New-onset stroke events include ischemic stroke, transient ischemic attack, and hemorrhagic stroke.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite and separate indicators of new clinical vascular events at 12 and 24 months</measure>
    <time_frame>12 months, 24 months</time_frame>
    <description>Clinical vascular events included ischemic stroke, transient ischemic attack, hemorrhagic stroke, myocardial infarction, and vascular death.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause deaths at 24 months</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">102072</enrollment>
  <condition>Head and Neck Vascular Stenosis</condition>
  <arm_group>
    <arm_group_label>Digital health management intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the trial group receives intervention management from the digital health management platform, including reminding patients to take medication on time, monitoring and managing risk factors, reminding patients to have regular checkups and regular follow-ups, and pushing personalized science based on patients' risk factors, etc. Meanwhile, the platform's customer service staff regularly follows up with patients and reminds them of health management, and regularly invites experts to conduct formal medical science conferences for patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The group doesn't not receive intervention reminders and customer service supervision from the platform, but receives the same follow-up visits.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Digital health management</intervention_name>
    <description>The digital health management platform mainly includes reminding patients to take medication on time, monitoring and managing risk factors, reminding patients of regular review and regular follow-up, pushing personalized science according to patients' risk factors, etc., as well as following up and supervising patients' health management, and conducting regular formal medical science conferences</description>
    <arm_group_label>Digital health management intervention Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Inclusion criteria of the clusters&#xD;
&#xD;
             Hospitals with the qualification of &quot;head and neck ultrasound center&quot; in China.&#xD;
&#xD;
          2. Inclusion criteria for individuals&#xD;
&#xD;
               -  (1)Age â‰¥ 35 years old, with no restriction on gender.&#xD;
&#xD;
               -  (2)Patients with clinically diagnosed head and neck stenosis or occlusion,&#xD;
                  including mild, moderate or severe stenosis or occlusion of the carotid artery&#xD;
                  and mild, moderate or severe stenosis or occlusion of the intracranial artery.&#xD;
&#xD;
               -  (3)Ability to use a smartphone and have a mobile application installed on the&#xD;
                  handset.&#xD;
&#xD;
               -  (4)Subjects or their legal representatives agreed to the study and signed the&#xD;
                  project informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Exclusion criteria for the clusters&#xD;
&#xD;
             The included centers did not have the capacity to undertake the trial.&#xD;
&#xD;
          2. Exclusion criteria for individuals&#xD;
&#xD;
               -  (1)Combination of severe systemic diseases such as respiratory failure, renal&#xD;
                  failure, gastrointestinal bleeding, coagulation dysfunction, malignancy, etc.&#xD;
&#xD;
               -  (2)Patients with a life expectancy of less than 2 years or who are unable to&#xD;
                  complete the study for other reasons.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yi Yang, MD, PhD</last_name>
    <phone>13756661217</phone>
    <phone_ext>0086</phone_ext>
    <email>doctoryangyi@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhenni Guo, MD, PhD</last_name>
    <phone>18186872986</phone>
    <phone_ext>0086</phone_ext>
    <email>zhen1ni2@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>First Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>March 22, 2023</study_first_submitted>
  <study_first_submitted_qc>March 22, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2023</study_first_posted>
  <last_update_submitted>April 3, 2023</last_update_submitted>
  <last_update_submitted_qc>April 3, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>The First Hospital of Jilin University</investigator_affiliation>
    <investigator_full_name>Yi Yang</investigator_full_name>
    <investigator_title>Associated Dean of First Hospital of Jilin University</investigator_title>
  </responsible_party>
  <keyword>head and neck vascular stenosis</keyword>
  <keyword>digital health management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

